Is it safe to order medicines online from Pinkline Exports?

Yes. We source medicines from verified manufacturers and licensed suppliers. Every order goes through quality verification before dispatch to ensure authenticity, proper packaging, and batch traceability wherever applicable.

How can I place an order?

You can place an order directly through our website, email, or customer support team. Simply share your prescription (if required), medicine details, and shipping information, and our team will guide you through the process step-by-step.

Will I receive tracking details for my shipment?

Yes. Once your order is dispatched, you will receive tracking information so you can monitor your shipment status and estimated delivery timeline.

How long does international shipping usually take?

Shipping times vary depending on the destination country and customs clearance. Most international deliveries are completed within 7–15 business days after dispatch.

Do I need a prescription to order medicines?

Some medicines require a valid prescription depending on the product and destination country regulations. Our team will inform you if documentation is needed before processing the order.

Will my package be discreetly packed?

Yes. Orders are packed securely and discreetly to maintain customer privacy and product safety during transit.

Can I contact someone before placing an order?

Absolutely. Our support team is available to answer questions about medicines, pricing, shipping, availability, and order status before you place your order.

How do you protect customer privacy and information?

Customer information and medical details are handled securely and only used for order processing and support purposes. We prioritize confidentiality and secure communication throughout the process.

Can I order medicines for a family member abroad?

Yes. You can arrange delivery for family members or loved ones in eligible countries, provided all required documentation and shipping details are correctly submitted.

Oncology Archives - Pinkline Exports

13 Oct

Oncology

Mebendazole and Gefitinib for Drug-Resistant Lung Cancer: What the New 2026 Study Actually Found

October 13, 2026
By Dr Adam Makis

New 2026 preclinical research explores mebendazole and gefitinib in drug-resistant lung cancer cells and mice. Learn the findings, limitations and why human benefit is not yet established.